Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatichanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier function. GUCY2C may represent a new target for anti-obesity pharmacotherapy.